Stathmin expression in glioma-derived microvascular endothelial cells: A novel therapeutic target

Oncology Reports

Volumn 27, Issue 3, 2012, Pages 714-718

  Dong, Baijing ^a   Mu, Luyan ^a   Qin, Xiangying ^a   Qiao, Wanchen ^a   Liu, Xiaodong ^b   Yang, Liming ^a   Xue, Li ^a   Rainov, Nikolai G ^c   Liu, Xiaoqian ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Department of Neurosurgery   (China)

^c KLINIKUM AUGSBURG   (Germany)

Author keywords

Glioma; Neoangiogenesis; Stathmin; Vascular endothelial cells

Indexed keywords

ANTIBODY; CD105 ANTIBODY; MESSENGER RNA; SMALL INTERFERING RNA; STATHMIN; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; APOPTOSIS; ARTICLE; CANCER GRADING; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS INHIBITION; MICROVASCULAR ENDOTHELIAL CELL; MIGRATION INHIBITION; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATHMIN GENE; TUMOR VASCULARIZATION; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; APOPTOSIS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; GLIOMA; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; RNA, SMALL INTERFERING; STATHMIN; YOUNG ADULT;

EID: 84863033408     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1525     Document Type: Article

References (25)

1. Folkman J: Tumor angiogenesis: therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
2. Sato K, Tsuchiya N, Sasaki R, et al: Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma. J Cancer Res 90: 874-879, 1999. (Pubitemid 29431367)
3. Yagasaki H, Kawata N, Takimoto Y, et al: Histopathological analysis of angiogenic factors in renal cell carcinoma. Int J Urol 10: 220-227, 2003. (Pubitemid 36606372)
4. Rubin CI and Atweh GF: The role of stathmin in the regulation of the cell cycle. J Cell Biochem 93: 242-250, 2004. (Pubitemid 44264202)
5. Bhat KM and Setaluri V: Microtubule-associated proteins as targets in cancer chemotherapy. Clin Cancer Res 13: 2849-2854, 2007. (Pubitemid 46849557)
6. Leibl S, Zigeuner R, Hutterer G, et al: EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology. APMIS 116: 27-32, 2008. (Pubitemid 351191103)
7. Cassimeris L: The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol 14: 18-24, 2002.
8. Rana S, Maples PB, Senzer N, et al: Stathmin 1: a novel therapeutic target for anticancer activity. Expert Rev Anticancer Ther 8: 1461-1470, 2008.
9. Nanda A and St Croix B: Tumor endothelial markers: new targets for cancer therapy. Curr Opin Oncol 16: 44-49, 2004. (Pubitemid 38703471)
10. St Croix B, Rago C, Velculescu V, et al: Genes expressed in human tumor endothelium. Science 289: 1197-1202, 2000. (Pubitemid 30650733)
11. Bussolati B, Deambrosis I, Russo S, et al: Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 17: 1159-1161, 2003.
12. Zhang X, Yamashita M, Uetsuki H, et al: Angiogenesis in renal cell carcinoma: evaluation of microvessel density, vascular endothelial growth factor and matrix metalloproteinases. Int J Urol 9: 509-514, 2002. (Pubitemid 35365569)
13. Unger RE, Oltrogge JB, Von Briesen H, et al: Isolation and molecular characterization of brain microvascular endothelial cells from human brain tumors. In Vitro Cell Dev Biol Anim 38: 273-281, 2002. (Pubitemid 35204975)
14. Bian XW, Jiang XF, Chen JH, et al: Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol 6: 90-99, 2006.
15. Miebach S, Grau S, Hummel V, et al: Isolation and culture of microvascular endothelial cells from gliomas of different WHO Grades. J Neurooncol 76: 39-48, 2006. (Pubitemid 43115757)
16. She X, Matsuno F, Harada N, et al: Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells. Int J Cancer 108: 251-257, 2004. (Pubitemid 37541779)
17. Naumov GN, Akslen LA and Folkman J: Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch. Cell Cycle 5: 1779-1787, 2006. (Pubitemid 44435320)
18. Ingber D, Prusty D, Zhengqi S, et al: Cell shape, cytoskeletal mechanics and cell cycle control in angiogenesis. J Biomech 28: 1471-1484, 1995. (Pubitemid 26004293)
19. Hayot C, Farinelle S, De Decker R, et al: In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton. Int J Oncol 21: 417-425, 2002.
20. Holmfeldt P, Sellin ME and Gullberg M: Predominant regulators of tubulin monomer-polymer partitioning and their implication for cell polarization. Cell Mol Life Sci 66: 3263-3276, 2009.
21. Sellin ME, Holmfeldt P, Stenmark S, et al: Global regulation of the interphase microtubule system by abundantly expressed Op18/stathmin. Mol Biol Cell 19: 2897-2906, 2008.
22. Budhachandra K, Brojen Singh RK and Menon GI: Microtubule dynamics regulated by stathmin. Comput Biol Chem 32: 141-144, 2008.
23. Mistry SJ and Atweh GF: Role of stathmin in the regulation of the mitotic spindle: Potential applications in cancer therapy. Mt Sinai J Med 69: 299-304, 2002. (Pubitemid 35244131)
24. Miyashita H, Kanemura M, Abe M, et al: Vascular endothelial zinc finger1 is i nvolved in the regulation of angiogenesis: possible contribution of stathmin/Op18 as a downstream target gene. Arterioscler Thromb Vasc Biol 24: 878-884, 2004. (Pubitemid 38620866)
25. Mistry SJ, Bank A and Atweh GF: Synergistic antiangiogenic effects of stathmin inhibition and taxol exposure. Mol Cancer Res 5: 773-782, 2007. (Pubitemid 47294805)